The following table shows the beneficial ownership of Ordinary Shares as of July 15, 2025 by each person known to us to be the beneficial owner of more than 5% of the Ordinary Shares.

Shareholder

Shares

%

Hoche Partners Pharma Holding LLC

773,031,209

32.44%

Flying Fish Ventures L.P.

484,202,796

20.75%

Becaril, S.A.

325,109,560

13.99%

Chemo Project S.A.

325,109,560

13.99%

Santana S.A.

170,096,318

7.35%

Compañía de Seguros de Vida Consorcio Nacional de Seguros S.A

158,403,294

6.88%

Free Float and Other Shareholders

226,315,866

4.60%

Total Shares Outstanding

2,462,268,603

100%


Investor Contact Information

Company

Sofgen Pharma
9 Rue De Bitbourg
L-1273 Luxembourg
Grand Duchy of Luxembourg

Investor Relations

Sofgen Pharma Company Contact
ir@SofgenPharma.com

Search Investor Relations